Your search returned 3 results.

Results
	1.	Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer. [electronic resource] by Fasano, Julie Hershman, Dawn Novik, Yelena Levinson, Benjamin Blozie, Kim Tiersten, Amy D Publication details: Breast care (Basel, Switzerland) Mar 2010 In: Breast care (Basel, Switzerland) vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. [electronic resource] by Dang, Chau Iyengar, Neil Datko, Farrah D'Andrea, Gabriella Theodoulou, Maria Dickler, Maura Goldfarb, Shari Lake, Diana Fasano, Julie Fornier, Monica Gilewski, Theresa Modi, Shanu Gajria, Devika Moynahan, Mary Ellen Hamilton, Nicola Patil, Sujata Jochelson, Maxine Norton, Larry Baselga, Jose Hudis, Clifford Producer: 20150420 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. [electronic resource] by Jhaveri, Komal Chandarlapaty, Sarat Lake, Diana Gilewski, Teresa Robson, Mark Goldfarb, Shari Drullinsky, Pamela Sugarman, Steven Wasserheit-Leiblich, Carolyn Fasano, Julie Moynahan, Mary Ellen D'Andrea, Gabriella Lim, Kristina Reddington, Laura Haque, Sofia Patil, Sujata Bauman, Lynne Vukovic, Vojo El-Hariry, Iman Hudis, Clifford Modi, Shanu Producer: 20141231 In: Clinical breast cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)